Description
Tirzepatide is a once‑weekly injectable peptide that acts as a dual GIP and GLP‑1 receptor agonist.
Original price was: $150.00.$125.00Current price is: $125.00.
Tirzepatide is a dual GIP and GLP‑1 agonist, FDA‑approved for type 2 diabetes and obesity management.
35 in stock
Tirzepatide is a once‑weekly injectable peptide that acts as a dual GIP and GLP‑1 receptor agonist.
| Weight | .07 lbs |
|---|
Reviews
There are no reviews yet.